Table 1.
Sociodemographic, mental health and HIV clinical characteristics at first patient reported outcome (PRO) measure for 1785 HIV-infected men and women in CNICS, 2005–2014
| Characteristic | Men | Women |
|---|---|---|
| N = 1493(83.6) | N = 292 (16.4) | |
| N (%) or Median (IQR) | N (%) or Median (IQR) | |
| Site | ||
| Fenway | 70 (4.7) | 3 (1.0) |
| UAB | 756 (50.6) | 203 (69.5) |
| UNC | 5 (0.3) | 3 (1.0) |
| UCSD | 381 (25.5) | 50 (17.1) |
| UCSF | 130 (8.7) | 14 (4.8) |
| UW | 151 (10.1) | 19 (6.5) |
| Year of first PRO | 2011 (2009, 2012) | 2010 (2009, 2012) |
| Recently entered CNICS Carea | ||
| No | 949 (63.6) | 191 (65.4) |
| Yes | 544 (36.4) | 101 (34.6) |
| Recently entered CNICS care with no evidence of prior recent careb | ||
| No | 1155 (77.4) | 236 (80.8) |
| Yes | 338 (22.6) | 56 (19.2) |
| Time from entry into CNICS to first PRO, days | 463 (82, 2,214) | 659 (100, 2,770) |
| Age | 44 (36, 51) | 46 (39, 52) |
| Race/ethnicity | ||
| White, non-Hispanic | 809 (54.2) | 74 (25.3) |
| Black, non-Hispanic | 440 (29.5) | 185 (63.6) |
| Hispanic | 203 (13.6) | 26 (8.9) |
| Other | 41 (2.8) | 7 (2.4) |
| HIV risk group | ||
| IDU | 192 (12.9) | 30 (10.3) |
| MSM | 1112 (74.5) | 7 (2.4)e |
| Heterosexual | 172 (11.5) | 251 (86.0) |
| Other | 17 (1.1) | 4 (1.4) |
| Depression status | ||
| Not depression (PHQ-9 < 10) | 1106 (74.1) | 207 (70.9) |
| Depressed (PHQ-9 ≥ 10) | 387 (25.9) | 85 (29.1) |
| Panic disorder | ||
| No symptoms | 1086 (72.7) | 216 (74.0) |
| Some symptoms | 241 (16.1) | 36 (12.3) |
| Panic disorder | 166 (11.1) | 40 (13.7) |
| Antidepressant use | ||
| No antidepressant prescription | 1093 (73.2) | 190 (65.1) |
| Antidepressant prescription | 400 (26.8) | 102 (34.9) |
| Drug use | ||
| No use | 726 (48.6) | 181 (62.0) |
| Current use | 217 (15.4) | 29 (9.9) |
| Past use | 550 (36.8) | 82 (28.1) |
| Alcohol usec | ||
| No high risk alcohol use | 1298 (86.9) | 259 (88.7) |
| High risk alcohol use | 195 (13.1) | 33 (11.3) |
| Previous mental health diagnosis | ||
| No | 750 (50.2) | 122 (41.8) |
| Yes | 743 (49.8) | 170 (58.2) |
| Previous medical diagnosis | ||
| No | 1077 (72.1) | 192 (65.8) |
| Yes | 416 (27.9) | 100 (34.2) |
| ART use and adherenced | ||
| Adherent, on ART | 1021 (68.4) | 187 (64.0) |
| Not adherent, on ART | 140 (9.4) | 37 (12.7) |
| Off ART | 332 (22.2) | 68 (23.3) |
| CD4 count, cells/mmc | 462 (291, 632) | 487 (314, 683) |
| Viral load suppression (< 50 copies/mL) | ||
| Undetectable viral load | 851 (57.0) | 175 (59.9) |
| Detectable viral load | 642 (43.0) | 117 (40.1) |
PRO patient-reported outcomes, MSM: men who have sex with men, IDU intravenous drug use
Defined as participants who had their baseline PRO measure within 6 months of their initial CNICS visit
Defined as participants who had their baseline PRO measure within 6 months of their initial CNICS visit and had a detectable viral load within 28 days of entering CNICS care
Defined as Alcohol Use Disorders Identification Test (AUDIT) score > 4 for males and > 3 for females
Adherence defined as no missed medication doses in the last week
A small proportion of persons identifying as ’female’ at entry into CNICS care endorsed MSM as their primary risk factor for HIV infection. Due to the small number, this group was combined with the “Other” category in statistical analyses